Evidence map›Paper›PMID 22419064›Full record

ArticleEpigenetics2012

DNA methylation in neonates born to women receiving psychiatric care.

James W Schroeder, Alicia K Smith, Patricia A Brennan, Karen N Conneely, Varun Kilaru, Bettina T Knight, D Jeffrey Newport, Joseph F Cubells, Zachary N Stowe

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00525226 (Perinatal Stress and Gene Influences), which is not on this map. Cited by 36 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 6 pooled it
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00525226 completednot on this map

Perinatal Stress and Gene Influences: Pathways to Infant Vulnerability

TypeobservationalSponsorEmory UniversityRan2007 to 2012Enrolled1,431ConditionsDepression, Panic Disorder, Generalized Anxiety Disorder, Post-Traumatic Stress Disorder
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 6 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

James W SchroederGenetics and Molecular Biology Program, Emory University, Atlanta, GA, USA.
Alicia K Smith
Patricia A Brennan
Karen N Conneely
Varun Kilaru
Bettina T Knight
D Jeffrey Newport
Joseph F Cubells
Zachary N Stowe
AID Atlanta · USEmory University · USInstitut thématique Génétique, génomique et bioinformatique · FR

Funding

The Impact of Maternal Depression, Anxiety, and StressP50MH077928 · NIMH · EMORY UNIVERSITY · PI NEWPORT, DONALD JEFFREY · 2007 to 2011
$9.6M
Mood and Anxiety Disorders in Pregnancy and LactationP50MH068036 · NIMH · EMORY UNIVERSITY · PI STOWE, ZACHARY N · 2002 to 2006
$6.1M
Epigenetic Biomarkers of Early Psychotropic Medication ExposureRC1MH088609 · NIMH · EMORY UNIVERSITY · PI BRENNAN, PATRICIA A, SMITH, ALICIA K · 2009 to 2010
$982k
Genetic & Environmental Risk Factors that Contribute to Childhood PsychopathologyK01MH085806 · NIMH · EMORY UNIVERSITY · PI SMITH, ALICIA K · 2010 to 2013
$522k
NIMH NIH HHS K01 MH085806NIMH NIH HHS MH085806NIMH NIH HHS P50 MH068036NIMH NIH HHS P50 MH077928NIMH NIH HHS P50 MH68036NIMH NIH HHS RC1 MH088609
6 · The paper itself

Abstract

Prenatal exposure both to maternal psychiatric illness and psychiatric medication has been linked with adverse child outcomes that affect physiological, emotional and psychiatric development. Studies suggest that epigenetic mechanisms, such as DNA methylation, may facilitate these effects. In this report, we explore the association between maternal psychiatric illness and treatment during pregnancy and neonatal DNA methylation patterns in a prospectively-characterized clinical cohort of 201 dyads. Associations between the percent of umbilical cord blood DNA methylated at 27,578 CpG sites and maternal psychiatric diagnosis, symptoms and antidepressant use were evaluated by fitting a separate linear mixed effects model for each CpG site. There were no significant changes in neonatal DNA methylation attributable to maternal psychiatric diagnosis or depressive symptoms during pregnancy. Exposure to an antidepressant medication was associated with differential methylation of CpG sites in TNFRSF21 and CHRNA2 (false discovery rate < 0.05), but the average difference in methylation for both CpG sites was less than 3% between each group. The results were not specific to type of antidepressant or duration of the exposure. This study suggests that there are no large effects of maternal psychiatric illness, depressive symptoms or prenatal exposure to antidepressants on neonatal DNA methylation. Delineation of the influence of maternal psychiatric illness and pharmacological exposures on the developing fetuses has critical implications for clinical care during pregnancy.

Indexed as

DNA MethylationAntidepressive AgentsAntiemeticsBupropionCpG IslandsFemaleFetal BloodGenome, HumanHumansHypnotics and SedativesInfant, NewbornMajor Depressive DisorderMalePregnancyPrenatal Exposure Delayed EffectsProspective StudiesAntidepressive AgentsAntiemeticsBupropionCHRNA2 protein, humanHypnotics and SedativesReceptors, NicotinicReceptors, Tumor Necrosis FactorTNFRSF21 protein, human

Identifiers

PMID22419064
PMCPMC3368823
OpenAlexW2010993240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.